Sequence variations in human immunodeficiency virus (HIV)-1 reverse transcriptase (RT) and protease, the molecular targets of anti-retroviral drug therapy, are prime examples of genes in which ...

Table 1, which samples currently approved protease inhibitors based on protease types, is notable for its brevity and the absence of new targets that have not already been known for decades (see Ref.

The treatment of hyperlipidemia in patients infected with HIV is discussed. Hyperlipidemia is common in HIV-infected patients receiving antiretroviral therapy, especially protease inhibitors and ...

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing ... target one of three viral proteins which control HIV’s lifecycle: reverse ...

On board the W-1 was an invaluable payload—space-produced ritonavir crystals that can be employed in the treatment of HIV. This organic compound inhibits the HIV protease in the human body ...